Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Rheumatoid Arthritis
Related studies linked through entity extraction aliases.
Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in Australia
- Status
- COMPLETED
- Phase
- N/A
A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate
- Status
- TERMINATED
- Phase
- PHASE2
Joint Ultrasound Evaluation of Asymptomatic Rheumatic Feet
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
- Status
- TERMINATED
- Phase
- PHASE3
A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)
- Status
- COMPLETED
- Phase
- N/A
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE3
Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)
- Status
- COMPLETED
- Phase
- N/A
A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE3
An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting
- Status
- COMPLETED
- Phase
- N/A
A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)
- Status
- COMPLETED
- Phase
- N/A
A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage
- Status
- TERMINATED
- Phase
- PHASE4
Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study
- Status
- TERMINATED
- Phase
- PHASE4